204 related articles for article (PubMed ID: 12668728)
1. Agonist-induced endocytosis of lysophosphatidic acid-coupled LPA1/EDG-2 receptors via a dynamin2- and Rab5-dependent pathway.
Murph MM; Scaccia LA; Volpicelli LA; Radhakrishna H
J Cell Sci; 2003 May; 116(Pt 10):1969-80. PubMed ID: 12668728
[TBL] [Abstract][Full Text] [Related]
2. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
3. The G protein-coupled receptor GPR4 suppresses ERK activation in a ligand-independent manner.
Bektas M; Barak LS; Jolly PS; Liu H; Lynch KR; Lacana E; Suhr KB; Milstien S; Spiegel S
Biochemistry; 2003 Oct; 42(42):12181-91. PubMed ID: 14567679
[TBL] [Abstract][Full Text] [Related]
4. Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid.
Fitzgerald LR; Dytko GM; Sarau HM; Mannan IJ; Ellis C; Lane PA; Tan KB; Murdock PR; Wilson S; Bergsma DJ; Ames RS; Foley JJ; Campbell DA; McMillan L; Evans N; Elshourbagy NA; Minehart H; Tsui P
Biochem Biophys Res Commun; 2000 Jul; 273(3):805-10. PubMed ID: 10891327
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms in LPA-induced tumor cell migration: critical role of phosphorylated ERK.
Stähle M; Veit C; Bachfischer U; Schierling K; Skripczynski B; Hall A; Gierschik P; Giehl K
J Cell Sci; 2003 Sep; 116(Pt 18):3835-46. PubMed ID: 12902401
[TBL] [Abstract][Full Text] [Related]
6. N-glycans of sphingosine 1-phosphate receptor Edg-1 regulate ligand-induced receptor internalization.
Kohno T; Wada A; Igarashi Y
FASEB J; 2002 Jul; 16(9):983-92. PubMed ID: 12087059
[TBL] [Abstract][Full Text] [Related]
7. Subtype-selective antagonists of lysophosphatidic Acid receptors inhibit platelet activation triggered by the lipid core of atherosclerotic plaques.
Rother E; Brandl R; Baker DL; Goyal P; Gebhard H; Tigyi G; Siess W
Circulation; 2003 Aug; 108(6):741-7. PubMed ID: 12885756
[TBL] [Abstract][Full Text] [Related]
8. Lysophosphatidic acid- and Gbeta-dependent activation of Dictyostelium MAP kinase ERK2.
Schenk PW; Epskamp SJ; Knetsch ML; Harten V; Lagendijk EL; van Duijn B; Snaar-Jagalska BE
Biochem Biophys Res Commun; 2001 Apr; 282(3):765-72. PubMed ID: 11401529
[TBL] [Abstract][Full Text] [Related]
9. Agonist-induced internalization of histamine H2 receptor and activation of extracellular signal-regulated kinases are dynamin-dependent.
Xu AJ; Kuramasu A; Maeda K; Kinoshita K; Takayanagi S; Fukushima Y; Watanabe T; Yanagisawa T; Sukegawa J; Yanai K
J Neurochem; 2008 Oct; 107(1):208-17. PubMed ID: 18691388
[TBL] [Abstract][Full Text] [Related]
10. Lysophosphatidic acid regulates the proliferation and migration of olfactory ensheathing cells in vitro.
Yan H; Lu D; Rivkees SA
Glia; 2003 Oct; 44(1):26-36. PubMed ID: 12951654
[TBL] [Abstract][Full Text] [Related]
11. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
[TBL] [Abstract][Full Text] [Related]
12. Common signaling pathways link activation of murine PAR-1, LPA, and S1P receptors to proliferation of astrocytes.
Sorensen SD; Nicole O; Peavy RD; Montoya LM; Lee CJ; Murphy TJ; Traynelis SF; Hepler JR
Mol Pharmacol; 2003 Nov; 64(5):1199-209. PubMed ID: 14573770
[TBL] [Abstract][Full Text] [Related]
13. Lysophosphatidic acid induces chemotaxis in MC3T3-E1 osteoblastic cells.
Masiello LM; Fotos JS; Galileo DS; Karin NJ
Bone; 2006 Jul; 39(1):72-82. PubMed ID: 16487757
[TBL] [Abstract][Full Text] [Related]
14. Differential stimulation of signaling pathways initiated by Edg-2 in response to lysophosphatidic acid or sphingosine-1-phosphate.
Peyruchaud O; Mosher DF
Cell Mol Life Sci; 2000 Jul; 57(7):1109-16. PubMed ID: 10961347
[TBL] [Abstract][Full Text] [Related]
15. Role of EGF receptor transactivation in phosphoinositide 3-kinase-dependent activation of MAP kinase by GPCRs.
Shah BH; Neithardt A; Chu DB; Shah FB; Catt KJ
J Cell Physiol; 2006 Jan; 206(1):47-57. PubMed ID: 15920762
[TBL] [Abstract][Full Text] [Related]
16. Betagamma subunits of G(i/o) suppress EGF-induced ERK5 phosphorylation, whereas ERK1/2 phosphorylation is enhanced.
Obara Y; Okano Y; Ono S; Yamauchi A; Hoshino T; Kurose H; Nakahata N
Cell Signal; 2008 Jul; 20(7):1275-83. PubMed ID: 18407464
[TBL] [Abstract][Full Text] [Related]
17. Endocytosis of adiponectin receptor 1 through a clathrin- and Rab5-dependent pathway.
Ding Q; Wang Z; Chen Y
Cell Res; 2009 Mar; 19(3):317-27. PubMed ID: 18982021
[TBL] [Abstract][Full Text] [Related]
18. Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate.
Im DS; Heise CE; Harding MA; George SR; O'Dowd BF; Theodorescu D; Lynch KR
Mol Pharmacol; 2000 Apr; 57(4):753-9. PubMed ID: 10727522
[TBL] [Abstract][Full Text] [Related]
19. Antidepressants activate the lysophosphatidic acid receptor LPA(1) to induce insulin-like growth factor-I receptor transactivation, stimulation of ERK1/2 signaling and cell proliferation in CHO-K1 fibroblasts.
Olianas MC; Dedoni S; Onali P
Biochem Pharmacol; 2015 Jun; 95(4):311-23. PubMed ID: 25888927
[TBL] [Abstract][Full Text] [Related]
20. Altered expression and functional profile of lysophosphatidic acid receptors in mitogen-activated human blood T lymphocytes.
Zheng Y; Voice JK; Kong Y; Goetzl EJ
FASEB J; 2000 Dec; 14(15):2387-9. PubMed ID: 11024010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
